Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

NCT01103284 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: DiaPep277
DRUG: Placebo

Sponsor

Andromeda Biotech Ltd.